Reneo Pharmaceuticals’ $93.8 Million Initial Public Offering

Latham & Watkins LLP represents the underwriters in the offering while Wilson Sonsini Goodrich & Rosati advised Reneo Pharmaceuticals, Inc.Reneo Pharmaceuticals, Inc. has announced the pricing of…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now